TWC
FBRX icon

TD Waterhouse Canada’s Forte Biosciences FBRX Stock Holding History

TD Waterhouse Canada’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4
Closed -$104 – 1765
2022
Q4 		$104 Hold
4
– – ﹤0.01% 1664
2022
Q3 		$110 Hold
4
– – ﹤0.01% 1676
2022
Q2 		$130 Hold
4
– – ﹤0.01% 1710
2022
Q1 		$151 Hold
4
– – ﹤0.01% 1747
2021
Q4 		$214 Buy
+4
New +$269 ﹤0.01% 1708

Other funds holding FBRX

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OWP
Old Well Partners Charlotte, North Carolina $4.55M AUM 27.75% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TD Waterhouse Canada's FBRX Position: Q1 2023 in Review

TD Waterhouse Canada sold out of Forte Biosciences (FBRX) in Q1 2023, closing a stake of 4 shares — an estimated $104 sold.

TD Waterhouse Canada first reported a position in FBRX in Q4 2021 and held it in 5 quarters. The position peaked at $214 in Q4 2021. 31 funds tracked by Wall St. Rank hold FBRX as of Q1 2023.

  • TD Waterhouse Canada reported no remaining Forte Biosciences position as of Q1 2023 after selling out during the quarter.
  • TD Waterhouse Canada sold 4 Forte Biosciences shares in Q1 2023, an estimated $104.
  • TD Waterhouse Canada first reported a position in Forte Biosciences in Q4 2021 and held it in 5 quarters.
  • TD Waterhouse Canada's Forte Biosciences position peaked at $214 in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2023.

Based on TD Waterhouse Canada's 13F filing for Q1 2023, filed 13 Nov 2023.